Cite

HARVARD Citation

    Ho, T. et al. (2016). Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine. Cephalalgia. pp. 148-161. [Online]. 
  
Back to record